Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD-related cirrhosis.

Devon ChangEmily TruongEdward A MenaFabiana PachecoMicaela WongMaha GuindiTsuyoshi T TodoNabil NoureddinWalid AyoubJu Dong YangIrene K KimAnita KohliNaim AlkhouriStephen HarrisonMazen Noureddin

Published in: Hepatology (Baltimore, Md.) (2022)

ML models performed better overall than FibroScan, FIB-4, FAST, and NFS. ML could be an effective tool for identifying clinically significant liver fibrosis and cirrhosis in patients with NAFLD.

Keyphrases

liver fibrosis
machine learning
artificial intelligence
big data